AGT-183

N/A

Report date: 2024/10/21 15:28:22

Base Information

Drug NameAGT-183

Drug Alias NameAGT-183

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionCerebroside-sulfatase stimulantsInsulin receptor modulators

TargetsCerebroside-sulfataseInsulin receptor

Therapy Area/IndicationsLeukodystrophy, Metachromatic

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesArmagen Inc

China Registration ClassN/A

Active CompaniesArmagen Inc

Inactive CompaniesN/A

Active IndicationsLeukodystrophy, Metachromatic

Inactive IndicationsN/A

ATC CodeN/A